Guggenheim Maintains Buy on Danaher, Raises Price Target to $250

Guggenheim analyst Subbu Nambi has maintained a Buy rating on Danaher (NYSE: DHR) and increased the price target from $200 to $250. This adjustment reflects a positive outlook for the company's performance.